Clinical trial
PROTECT: Pacing to Protect Heart for Damage From Blocked Heart Vessel and From…
NCT00409604 · Guidant Corporation, Industry · Completed
Key facts
| NCT number | NCT00409604 |
|---|---|
| Title | PROTECT : Pacing to Protect Heart for Damage From Blocked Heart Vessel and From Re-opening Blocked Vessel(s) |
| Official title | Clinical Evaluation of Pacing During the Onset of Revascularization / Feasibility Study |
| Lead sponsor | Guidant Corporation, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Acute Myocardial Infarction |
| Intervention type | Device |
| Interventions | Temporary RV VVI pacing |
| Enrollment | 60 |
| Start date | Dec 1, 2006 |
| Primary completion | Aug 1, 2009 |
| Completion | Aug 1, 2009 |
| First posted | Dec 11, 2006 |
| Last update posted | Aug 31, 2010 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: